Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 5/2016

01-05-2016 | Original Paper

Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes

Authors: Chunrong Liu, Mei Song, Jiwen Wang

Published in: Child's Nervous System | Issue 5/2016

Login to get access

Abstract

Objective

The objective of this study was to explore the feasibility of nightly oral administration of topiramate for treating benign childhood epilepsy with centrotemporal spikes (BECTS).

Methods

Eighty-five children with BECTS receiving topiramate treatment were randomly divided into A group (44 patients) and B group (41 patients). In A group, topiramate was orally administrated once a night, with a final dose of 2 mg/kg/day. In B group, topiramate was orally administrated twice a day, with a final dose of 4 mg/kg/day. At the end of the 12-month follow-up period, clinical efficacy, changes in electroencephalographic (EEG) activity, and adverse reactions were analyzed.

Results

There was no significant difference in overall efficacy rate, percentages of patients achieving seizure free, or changes in EEG activity between the two groups (P > 0.05). The rate of adverse reactions for A group was 9.1 %, which was significantly lower than the 29.3 % for B group (χ 2 = 4.262, P < 0.05).

Conclusion

Nightly oral administration of topiramate is a feasible strategy for the treatment of BECTS, with the advantages of comparable efficacy, convenience, and fewer adverse reactions.
Literature
1.
Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M (2008) Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain 131:2264–2286CrossRefPubMed
2.
Stephani U (2000) Typical semiology of benign childhood epilepsy with centrotemporal spikes (BCECTS). Epileptic Disord 2(Suppl 1):S3–S4PubMed
3.
Vears DF, Tsai MH, Sadleir LG, Grinton BE, Lillywhite LM, Carney PW, Harvey AS, Berkovic SF, Scheffer IE (2012) Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia 53:319–324CrossRefPubMed
4.
Neubauer BA, Hahn A, Stephani U, Doose H (2002) Clinical spectrum and genetics of Rolandic epilepsy. Adv Neurol 89:475–479PubMed
5.
Ford LM, Todd MJ, Polverejan E (2013) Effect of topiramate monotherapy on height in newly diagnosed children with epilepsy. Pediatr Neurol 48:383–389CrossRefPubMed
6.
Ciumas C, Saignavongs M, Ilski F, Herbillon V, Laurent A, Lothe A, Heckemann RA, de Bellescize J, Panagiotakaki E, Hannoun S, Marinier DS, Montavont A, Ostrowsky-Coste K, Bedoin N, Ryvlin P (2014) White matter development in children with benign childhood epilepsy with centro-temporal spikes. Brain 137:1095–1106CrossRefPubMed
7.
You SJ, Kim DS, Ko TS (2006) Benign childhood epilepsy with centro-temporal spikes (BCECTS): early onset of seizures is associated with poorer response to initial treatment. Epileptic Disord 8:285–288PubMed
8.
Miziara CS, Manreza ML (2002) Benign focal epilepsy of childhood with centrotemporal spikes (BECTS): clinical characteristics of seizures according to age at first seizure. Arq Neuropsiquiatr 60:390–394CrossRefPubMed
9.
Matthews CK, Maganti R (2014) Four-year-old girl with abnormal EEG on routine overnight polysomnogram for snoring and behavioral issues. Benign Rolandic epilepsy (BRE) or benign epilepsy of childhood with centrotemporal spikes (BECTS). J Clin Sleep Med 10:109–110PubMedPubMedCentral
10.
Panayiotopoulos CP (2005) The epilepsies: seizures, syndromes and management. Benign childhood focal seizures and related epileptic syndromes, 2010/09/08 edn. Oxfordshire (UK): Bladon Medical Publishing
11.
Camfield CS, Berg A, Stephani U, Wirrell EC (2014) Transition issues for benign epilepsy with centrotemporal spikes, nonlesional focal epilepsy in otherwise normal children, childhood absence epilepsy, and juvenile myoclonic epilepsy. Epilepsia 55(Suppl 3):16–20CrossRefPubMed
12.
Garcia-Ramos C, Jackson DC, Lin JJ, Dabbs K, Jones JE, Hsu DA, Stafstrom CE, Zawadzki L, Seidenberg M, Prabhakaran V, Hermann BP (2015) Cognition and brain development in children with benign epilepsy with centrotemporal spikes. Epilepsia 56:1615–1622CrossRefPubMed
13.
Saeed M, Azam M, Shabbir N, Qamar SA (2014) Is “benign childhood epilepsy with centrotemporal spikes” always benign? Iran J Child Neurol 8:38–43PubMedPubMedCentral
14.
Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28:499–521
15.
Capdevila OS, Dayyat E, Kheirandish-Gozal L, Gozal D (2008) Prevalence of epileptiform activity in healthy children during sleep. Sleep Med 9:303–309CrossRefPubMed
16.
Miano S, Bachiller C, Gutierrez M, Salcedo A, Villa MP, Peraita-Adrados R (2010) Paroxysmal activity and seizures associated with sleep breathing disorder in children: a possible overlap between diurnal and nocturnal symptoms. Seizure 19:547–552CrossRefPubMed
17.
18.
Tan HJ, Singh J, Gupta R, de Goede C (2014) Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. Cochrane Database Syst Rev 9:CD006779PubMed
19.
Xiao F, An D, Deng H, Chen S, Ren J, Zhou D (2014) Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS). Seizure 23:756–761CrossRefPubMed
20.
Xiao F, An D, Chen S, Ren J, Zhou D (2015) Clinical and electroencephalographic (EEG) features associated with refractoriness in benign childhood epilepsy with centrotemporal spikes. J Child Neurol 30:1591–1597CrossRefPubMed
21.
Markind JE (1998) Topiramate: a new antiepileptic drug. Am J Health Syst Pharm 55:554–562PubMed
22.
Rudakova I (2012) Pharmacotherapy of epilepsy: the use of topiramate in initial and additional treatment. Zh Nevrol Psikhiatr Im S S Korsakova 112:58–64PubMed
23.
Rating D (2000) Treatment in typical and atypical Rolandic epilepsy. Epileptic Disorders International Epilepsy Journal with Videotape 2(Suppl 1):S69–S72PubMed
24.
Peters JM, Camfield CS, Camfield PR (2001) Population study of benign Rolandic epilepsy: is treatment needed? Neurology 57:537–539CrossRefPubMed
25.
Samaitiene R, Norkuniene J, Jurkeviciene G, Grikiniene J (2012) Behavioral problems in children with benign childhood epilepsy with centrotemporal spikes treated and untreated with antiepileptic drugs. Medicina (Kaunas) 48:338–344
26.
Basnec A, Skarpa D, Barisic N, Jurin M, Mucic-Pucic B (2005) The risk of second seizure in children with benign childhood epilepsy with centrotemporal spikes without treatment—a prospective study. Acta Med Croatica 59:59–62PubMed
27.
Incecik F, Altunbasak S, Herguner OM, Mert G, Sahan D (2015) Prognostic significance of failure of the initial antiepileptic drug in children with benign childhood epilepsy with centrotemporal spikes. Brain and Development 37:66–70CrossRefPubMed
28.
Guerrini R, Carpay J, Groselj J, van Oene J, Schreiner A, Lahaye M, Schwalen S (2005) Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Seizure 14:371–380CrossRefPubMed
29.
Corda D, Gelisse P, Genton P, Dravet C, Baldy-Moulinier M (2001) Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes. Epilepsia 42:754–759CrossRefPubMed
30.
Kang HC, Hu Q, Liu XY, Liu ZG, Zeng Z, Liu JL, Wang M, Liang YL, Zhu SQ (2012) A follow-up study on newer anti-epileptic drugs as add-on and monotherapy for partial epilepsy in China. Chin Med J 125:646–651PubMed
31.
Privitera MD (1997) Topiramate: a new antiepileptic drug. Ann Pharmacother 31:1164–1173PubMed
Metadata
Title
Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes
Authors
Chunrong Liu
Mei Song
Jiwen Wang
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 5/2016
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-016-3043-0

Other articles of this Issue 5/2016

Child's Nervous System 5/2016 Go to the issue

Original Paper

Pediatric spinal arteriovenous malformations and fistulas: a single institute’s experience

Letter to the Editor

Undifferentiated meningeal sarcoma of childhood presenting as hard mass adhered to major intracranial vessels

Letter to the Editor

Chronic subdural hematoma associated with mucopolysaccharidosis type III B (Sanfilippo’s syndrome B)

Case Report

Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report

Case Report

X-linked hypophosphatemic rickets and sagittal craniosynostosis: three patients requiring operative cranial expansion: case series and literature review

Original Paper

Functional outcomes of infants with Narakas grade 1 birth-related brachial plexus palsy undergoing neurotization compared with infants who did not require surgery